Evidence map›Paper›PMID 40943851›Full record

ArticleJournal of clinical medicine2025

Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases?

Salim Mısırcı, Ali Ekin, Burcu Yağız, Belkıs Nihan Coşkun, Mustafa Çağatay Büyükuysal, Ediz Dalkılıç, Yavuz Pehlivan

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Salim MısırcıDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey.ORCID 0000-0002-9362-1855
Ali EkinDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey.ORCID 0000-0003-3692-1293
Burcu YağızDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey.ORCID 0000-0002-0624-1986
Belkıs Nihan CoşkunDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey.ORCID 0000-0003-0298-4157
Mustafa Çağatay BüyükuysalDepartment of Biostatistics, Faculty of Medicine, Zonguldak Bülent Ecevit University, Zonguldak 67630, Turkey.ORCID 0000-0001-9810-5633
Ediz DalkılıçDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey.
Yavuz PehlivanDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bDMARDdenosumabinfectionosteoporosistsDMARD

Identifiers

PMID40943851
PMCPMC12428897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.